title: Outcome of pediatric renal transplantation in Labfi Nejad Hospital, Tehran, Iran.
abstract: Kidney transplantation is the treatment of choice for children with end-stage renal disease. In Iran, a kidney transplantation program was started in the Labfi Nejad Hospital, Tehran in 1985. From 1985 to 2003, 278 children (mean age 11.6 years, 59.7% males) received their first renal transplant. All transplants were donations from live donors (12.5% live-related donors); 30.8% of patients were preemptively transplanted. The overall 1-year patient survival rate was 92% and the 5-year survival rate 74%. The median graft survival time was 7.2 years. The rate of graft survival was 88.8% at 1 year, 77% at 3 years, 67% at 5 years, 50% at 7 years, and 43% at 10 years after transplantation. The survival rate of patients and transplants improved significantly with time (p<0.05). In patients transplanted before 1997, the 5-year graft survival was 50% and 82% in patients transplanted after 1997. At the same time intervals, the frequency of acute rejection episodes was 66.6 versus 40.8% and of chronic rejection 50.5 versus 28.7%. The outcome in children below the age of 6 years was poor. Graft survival was negatively correlated with the frequency and an early time point of acute rejection episodes. The modus of transplantation (preemptive or postdialysis) did not influence the results. In conclusion, patient and graft survival in transplanted children significantly improved with time, thus reflecting greater medical and surgical experience, new immunosuppressive drugs, and better compliance.
authors.affiliation: Labfi Nejad Hospital, Shahid Beheshti University, Zafar Avenue, Tehran, Iran. hasanotukesh@yahoo.com
authors.forename: Hasan
authors.initials: H
authors.lastname: Otukesh
authors.forename: Abbas
authors.initials: A
authors.lastname: Basiri
authors.forename: Naser
authors.initials: N
authors.lastname: Simfrosh
authors.forename: Rozita
authors.initials: R
authors.lastname: Hoseini
authors.forename: Mostapha
authors.initials: M
authors.lastname: Sharifian
authors.forename: Nader
authors.initials: N
authors.lastname: Sadigh
authors.forename: Pedram
authors.initials: P
authors.lastname: Golnari
authors.forename: Mehdi
authors.initials: M
authors.lastname: Rezai
authors.forename: Mohamad
authors.initials: M
authors.lastname: Fereshtenejad
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005190:Family; D005260:Female; D006084:Graft Rejection / Q000503:physiopathology; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007492:Iran; D007676:Kidney Failure, Chronic / Q000503:physiopathology* / Q000601:surgery*; D016030:Kidney Transplantation / Q000401:mortality / Q000502:physiology* / Q000706:statistics & numerical data; D019520:Living Donors / Q000706:statistics & numerical data; D008297:Male; D012189:Retrospective Studies; D015996:Survival Rate; D009927:Tissue and Organ Procurement / Q000379:methods; D016896:Treatment Outcome